Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis
Maria Pia Amato(University of Florence), María Trojano(University of Bari Aldo Moro), Marco Onofrj(University of Chieti-Pescara), Paolo Gallo(University of Padua), Benedetta Goretti(University of Florence), Giovanna Borriello, Eleonora Cocco(University of Cagliari), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Vincenzo Brescia Morra(Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari), Valentina Zipoli(University of Florence)
Cited by 20
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Multiple Sclerosis Severity Score
|Neurology|2005|959
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624